UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | N | O | P | Q | R | S | T | V | W | X | Y | Z
Number of items: 158.

A

Atabani, SF and Divanovic, S and Trompette, A and Belkaid, Y and Thomas, DL and Karp, CL (2005) Association of CTLA4 polymorphism with regulatory T cell frequency. European Journal of Immunology , 35 (7) 2157 - 2162. 10.1002/eji.200526168.

Atadzhanov, M and Zumla, A and Mwaba, P (2005) Study of familial Parkinson's disease in Russia, Uzbekistan, and Zambia. POSTGRAD MED J , 81 (952) 117 - 121. 10.1136/pgmj.2004.018705.

B

Babiker, AG and Breckenridge, A and Darbyshire, JH and Dunn, DT and Fakoya, A and Fisher, M and Brown, AL and Loveday, C and McCormack, S and Pillay, D and Poppa, A and Rinehart, A and Verbiest, W and Williams, I and ERA Trial Investigators, (2005) A randomized controlled trial of the clinical utility of genotypic resistance testing in patients with limited prior exposure to antiretroviral drugs. HIV CLIN TRIALS , 6 (4) 183 - 186.

Batt, SL and Charalambous, BA and McHugh, TD and Martin, S and Gillespie, SH (2005) Novel PCR-Restriction fragment length polymorphism method for determining serotypes or serogroups of Streptococcus pneumoniae isolates. J CLIN MICROBIOL , 43 (6) 2656 - 2661. 10.1128/JCM.43.6.2656-2661.2005.
An open access publication

Blackham, J and Burns, S and Cameron, S and Cane, P and Chrystie, I and Churchill, D and Clarke, J and Easterbrook, P and Zuckerman, M and Goldberg, D and Gompels, M and Hale, T and Lazarus, L and Leigh-Brown, A and Loveday, C and Geretti, AM and Pillay, D and Phillips, A and Sabin, C and Hill, T and Kellam, P and Dunn, D and Porter, K and Green, H and Matthias, R and Pozniak, A and Tilston, P and Williams, I and Babiker, A and Dunn, D and Fisher, M and Gilson, R and Johnson, M and Mortimer, J and Peters, B and Porter, K and Scullard, G and Gazzard, B and Bansi, L and Smith, C and Waters, A and Crates, D and Morgan, N and Perry, N and Pullin, A and Harris, W and Bulbeck, S and Mandalia, S and Gilson, R and Dodds, J and Fudge, N and Rider, A and Williams, I and Sinka, K and Evans, B and Delpech, V and Larbalestier, N and Gray, K and Johnson, M and Youle, M and Lampe, F and Gumley, H and Chaloner, C and Puradiredja, J and Weber, J and Clarke, J and Owens, C and UK Collaborative Grp HIV Drug Resist, and UK CHIC Study Grp, (2005) Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice. AIDS , 19 (5) 487 - 494.

Breuer, J (2005) Commentary on varicella vaccination of children in the United States: Assessment after the first decade 1995-2005. J CLIN VIROL , 33 (2) 96 - 98. 10.1016/j.jcv.2005.03.003.

Breuer, J (2005) Varicella vaccination for healthcare workers - Is beneficial to patients and staff. BRIT MED J , 330 (7489) 433 - 434.

Breuer, J (2005) Varicella vaccination for healthcare workers. BMJ , 330 (7489) 433 - 434. 10.1136/bmj.330.7489.433.

C

Cane, P and Chrystie, I and Dunn, D and Evans, B and Geretti, AM and Green, H and Phillips, A and Pillay, D and Porter, K and Pozniak, A and Sabin, C and Smit, E and Weber, J and Zuckerman, M and Hill, T (2005) Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study. BMJ , 331 (7529) 1358 - ?.

Caplin, B and Sweny, P and Burroughs, A and Emery, V and Griffiths, P (2005) Antiviral treatment after solid organ transplantation. LANCET , 366 (9488) 806 - 807.

Caplin, B and Sweny, P and Burroughs, A and Emery, V and Griffiths, P (2005) Antiviral treatment after solid organ transplantation. Lancet , 366 (9488) 806 - 807. 10.1016/S0140-6736(05)67210-8.

Caplin, B and Sweny, P and Burroughs, A and Emery, V and Griffiths, P and Hodson, EM and Jones, CA and Webster, AC and Strippoli, GFM and Craig, JC (2005) Antiviral treatment after solid organ transplantation [5] (multiple letters). Lancet , 366 (9488) 806 - 807.

Cepeda, JA and Whitehouse, T and Cooper, B and Hails, J and Jones, K and Kwaku, F and Taylor, L and Hayman, S and Cookson, B and Show, S and Kibbler, C and Singer, M and Bellingan, G and Wilson, APR (2005) Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. LANCET , 365 (9456) 295 - 304.

Chilton, D and Dervisevic, S and Pillay, D and Rider, A and Copas, A and Miller, RF and Edwards, SG (2005) Determinants of HIV drug resistance mutations in plasma virus after treatment interruption. AIDS , 19 (18) 2174 - 2175.

Conaty, SJ and Claxton, AP and Enoch, DA and Hayward, AC and Lipman, MCI and Gillespie, SH (2005) The interpretation of nucleic acid amplification tests for tuberculosis: do rapid tests change treatment decisions? J INFECTION , 50 (3) 187 - 192. 10.1016/j.jinf.2004.03.010.

Cooper, BS and Stone, SR and Kibbler, CC and Cookson, BD and Roberts, JA and Medley, GF and Duckworth, GJ and Lai, R and Ebrahim, S (2005) Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: A review of the literature with epidemiological and economic modeling. INT J TECHNOL ASSESS , 21 (1) 146 - 146. 10.1017/S0266462305240199.

Creer, D.D. and Dilworth, J.P. and Gillespie, S.H. and Johnston, A.R. and Johnston, S.L. and Ling, C. and Patel, S. and Sanderson, G. and Wallace, P.G. and McHugh, T.D. (2005) Aetiological role of viral and bacterial infections in acute adult lower respiratory tract infection (LRTI) in primary care. Thorax , 61 (1) pp. 75-79. 10.1136/thx.2004.027441.
An open access version is available from UCL Discovery
file

Creer, DD and Dilworth, JP and Gillespie, SH and Johnston, AR and Johnston, SL and Ling, C and Patel, S and Sanderson, G and Wallace, PG and McHugh, TD (2005) Aetiological role of viral and bacterial infections in acute adult lower respiratory tract infection (LRTI) in primary care. Thorax , 61 (1) 75 - 79. 10.1136/thx.2004.027441.

D

Dale, JW and Bothamley, GH and Drobniewski, F and Gillespie, SH and McHugh, TD and Pitman, R (2005) Origins and properties of Mycobacterium tuberculosis isolates in London. J MED MICROBIOL , 54 (6) 575 - 582. 10.1099/jmm.0.45959-0.

Dheda, K and Booth, H and Huggett, JF and Johnson, MA and Zumla, A and Rook, GAW (2005) Lung remodeling in pulmonary tuberculosis. J INFECT DIS , 192 (7) 1201 - 1210.

Dheda, K and Booth, H and Huggett, JF and Johnson, MA and Zumla, A and Rook, GAW (2005) Lung remodelling in tuberculosis. The Journal of Infectious Diseases , 192 (7) 1201 - 1210.

Dheda, K and Chang, JS and Breen, AM and Kim, LU and Haddock, JA and Huggett, JF and Johnson, MA and Rook, GAW and Zumla, A (2005) In vivo and in vitro studies of a novel cytokine, interleukin 4 delta 2, in pulmonary tuberculosis. AM J RESP CRIT CARE , 172 (4) 501 - 508. 10.1164/rccm.200502-278OC.

Dheda, K and Chang, JS and Breen, RAM and Haddock, JA and Lipman, MC and Kim, LU and Huggett, JF and Johnson, MA and Rook, GAW and Zumla, A (2005) Expression of a novel cytokine, IL-4deltaf in HIV and HIV-tuberculosis co-infection. AIDS , 19 (15) 1601 - 1606.

Dheda, K and Chang, JS and Kim, LU and Huggett, JF and Johnson, MA and Zumla, A and Rook, GAW (2005) Interferon gamma assays for tuberculosis. LANCET INFECT DIS , 5 (6) 324 - 325.

Dheda, K and Huggett, JF and Chang, JS and Kim, LU and Bustin, SA and Johnson, MA and Rook, GAW and Zumla, A (2005) The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization. ANAL BIOCHEM , 344 (1) 141 - 143. 10.1016/j.ab.2005.05.022.

Dheda, K and Lalvani, A and Miller, RF and Scott, G and Booth, H and Johnson, MA and Zumla, A and Rook, GAW (2005) Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS , 19 (17) 2038 - 2041.

Dheda, K and Lampe, F and Lipman, MC and Johnson, MA and Rook, GA (2005) Reply to Lu et al. The Journal of Infectious Diseases , 192 (9) 1674 - 1675.

Dheda, K and Lampe, F and Lipman, MC and Johnson, MA and Rook, GAW (2005) HIV and leprosy in the eastern United States - Reply. J INFECT DIS , 192 (9) 1674 - 1675.

Dheda, K and Udwadia, ZF and Huggett, JF and Johnson, MA and Rook, GAW (2005) Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis. CURR OPIN PULM MED , 11 (3) 195 - 202.

Dheda, K. and Chang, J.-S. and Breen, R.A.M. and Kim, L.U. and Haddock, J.A. and Huggett, J.F. and Johnson, M.A. and Rook, G.A.W. and Zumla, A. (2005) In vivo and In vitro studies of a novel cytokine, interleukin 4 2, in pulmonary tuberculosis. American Journal of Respiratory and Critical Care Medicine , 172 (4) pp. 501-508. 10.1164/rccm.200502-278OC.

Dheda, K. and Lalvani, A. and Miller, R. and Scott, G. and Booth, H. and Johnson, M.A. and Zumla, A. and Rook, G.A.W. (2005) Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS , 19 (17) pp. 2038-2041.

Divanovic, S and Trompette, A and Atabani, SF and Madan, R and Golenbock, DT and Visintin, A and Finberg, RW and Tarakhovsky, A and Voge, SN and Belkaid, Y and Kurt-Jones, EA and Karp, CL (2005) Negative regulations of Toll-like receptor 4 signalling by the Toll-like receptor homolog RP105. Nature Immunology , 6 (6) 571 - 578. 10.1038/ni1198.

Doherty, TM and Demissie, A and Menzies, D and Andersen, P and Rook, G and Zumla, A and VACSEL Study Grp, (2005) Effect of sample handling on analysis of cytokine responses to Mycobacterium tuberculosis in clinical samples using ELISA, ELISPOT and quantitative PCR. J IMMUNOL METHODS , 298 (1-2) 129 - 141. 10.1016/j.jim.2005.01.013.

Dunn, DT and Green, H and Loveday, C and Rinehart, A and Pillay, D and Fisher, M and McCormack, S and Babiker, AG and Darbyshire, JH and Evaluation of Resistance Assays (ERA) Trial Investigators, (2005) A randomized controlled trial of the value of phenotypic testing in addition to genotypic testing for HIV drug resistance: evaluation of resistance assays (ERA) trial investigators. J Acquir Immune Defic Syndr , 38 (5) 553 - 559.

E

Eickholt, BJ and Towers, GJ and Ryves, WJ and Eikel, D and Adley, K and Ylinen, LMJ and Chadborn, NH and Harwood, AJ and Nau, H and Williams, RSB (2005) Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, glycogen synthase kinase-3 beta inhibition, and viral replication: A screening approach for new bipolar disorder drugs derived from the valproic acid core structure. MOL PHARMACOL , 67 (5) 1426 - 1433. 10.1124/mol.104.009308.

F

Fatkenheuer, G and Pozniak, AL and Johnson, MA and Plettenberg, A and Staszewski, S and Hoepelman, AI and Saag, MS and Goebel, FD and Rockstroh, JK and Dezube, BJ and Jenkins, TM and Medhurst, C and Sullivan, JF and Ridegway, C and Abel, S and James, IT and Youle, M and van der Ryst, E (2005) Efficacy of short-term monotherapy wiht maraviroc, a new CCR5 antagonist, in patients infected with HIV-1. Nature Medicine , 11 (11) 1170 - 1172. 10.1038/nm1319.

G

Garson, J and Creange, A and Dolei, A and Ferrante, P and Jouvin-Marche, E and Marche, PN and Rieger, F and Ruprecht, K and Saresella, M and Sotgiu, S and Tedder, R and Perron, H (2005) MSRV, Syncytin and the role of endogenous retroviral proteins in demyelination. MULTIPLE SCLEROSIS JOURNAL , 11 (2) 249 - 250. 10.1191/1352458505ms1160xx.
An open access version is available from UCL Discovery
file

Garson, JA and Grant, PR and Ayliffe, U and Ferns, RB and Tedder, RS (2005) Real-time PCR quantitation of hepatitis B virus DNA using automated sample preparation and murine cytomegalovirus internal control. J VIROL METHODS , 126 (1-2) 207 - 213. 10.1016/j.jviromet.2005.03.001.
An open access version is available from UCL Discovery
file

Gay, PB and Gillespie, SH (2005) Antibiotic resistance markers in genetically modified plants: a risk to human health? LANCET INFECT DIS , 5 (10) 637 - 646.

Geretti, AM and Sabin, C and Dunn, D and Nebbia, G (2005) Mutations at reverse transcriptase (RT) codons G196, Q207, H208, R211 and L214 are associated with drug experience and specific RT mutation patterns. In: ANTIVIRAL THERAPY. (pp. S104 - S104). INT MEDICAL PRESS LTD

Geretti, AM and Sabin, C and Dunn, D and Nebbia, G and UK Collaborative HIV Cohort, and UK Collaborative HIV Cohort, (2005) Mutations at reverse transcriptase (RT) codons G196, Q207, H208, R211 and L214 are associated with drug experience and specific RT mutation patterns. In: ANTIVIRAL THERAPY. (pp. S104 - S104). INT MEDICAL PRESS LTD

Gifford, R and Pillay, D and UK Collaborat Grp HIV-1 Drug, (2005) Utilisation of HIV-1 subtype specific consensus sequences to explore treatment related mutational patterns within and between subtypes. In: ANTIVIRAL THERAPY. (pp. S153 - S153). INT MEDICAL PRESS LTD

Gifford, R and Pillay, D and UK HIV-1 Drug Resistance Grp, (2005) Utilisation of HIV-1 subtype specific consensus sequences to explore treatment related mutational patterns within and between subtypes. In: ANTIVIRAL THERAPY. (pp. S153 - S153). INT MEDICAL PRESS LTD

Gillespie, SH (2005) Diagnosis of parasitic infections. In: Cox, FEG and Wakelin, D and Gillespie, SH and Despommier, DD, (eds.) Microbiology and Microbial Infections. Hodder Arnold

Gillespie, SH and Basu, S and Dickens, AL and O'Sullivan, DM and McHugh, TD (2005) Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates. J ANTIMICROB CHEMOTH , 56 (2) 344 - 348. 10.1093/jac/dki191.
An open access version is available from UCL Discovery
file

Gillespie, SH and Gosling, RD and Uiso, L and Sam, NE and Kanduma, EG and McHugh, TD (2005) Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis. J ANTIMICROB CHEMOTH , 56 (6) 1169 - 1171. 10.1093/jac/dki376.

Godfrey, A and Anderson, J and Papanastasiou, A and Takeuchi, Y and Boshoff, C (2005) Inhibiting primary effusion lymphoma, by lentiviral vectors encoding short hairpin RNA. BLOOD , 105 (6) 2510 - 2518. 10.1182/blood-2004-08-3052.

Griffiths, PD and Walter, S (2005) Cytomegalovirus. CURR OPIN INFECT DIS , 18 (3) 241 - 245.

Grover, D and Allen, L and Edwards, SG and Green, H and Copas, A and Forsyth, S and Pillay, D and UK CHIC, (2005) Predictors of death, and response to therapy in patients with multi (three)-class drug resistant (MDR) HIV in the UK. In: ANTIVIRAL THERAPY. (pp. S7 - S7). INT MEDICAL PRESS LTD

Grover, D and Allen, L and Edwards, SG and Green, H and Copas, A and Forsyth, S and Pillay, D and UK Collaborative Grp HIV Drug, and UK Collaborative HIV Cohort Study, (2005) Predictors of death, and response to therapy in patients with multi (three)-class drug resistant (MDR) HIV in the UK. In: ANTIVIRAL THERAPY. (pp. S7 - S7). INT MEDICAL PRESS LTD

Grover, D and Allen, L and Pillay, D and Green, H and Copas, A and Forsyth, S and Edwards, SG and on, BOTUKCGOHIVDRAUKCHIVCSUKCHIC (2005) Virological and clinical outcomes in patients with multi (three)-class drug resistant (MDR) HIV in the UK. In: (Proceedings) 11th Annual Conference of the British HIV Association with the British Association for Sexual Health and HIV (BASHH), Dublin, Ireland..

H

Handley, ME and Pollara, G and Chain, BM and Katz, DR (2005) The use of targeted microbeads for quantitative analysis of the phagocytic properties of human monocyte-derived dendritic cells. J IMMUNOL METHODS , 297 (1-2) 27 - 38. 10.1016/j.jim.2004.11.009.

Handley, ME and Thakker, M and Pollara, G and Chain, BM and Katz, DR (2005) JNK activation limits dendritic cell maturation in response to reactive oxygen species by the induction of apoptosis. Free Radic Biol Med , 38 (12) 1637 - 1652. 10.1016/j.freeradbiomed.2005.02.022.

Hernandez-Pando, R and Aguilar-Leon, D and Orozco, H and Serrano, A and Ahlem, C and Trauer, R and Schramm, B and Reading, C and Fincke, J and Rook, GAW (2005) 16 alpha-bromoepiandrosterone restores T helper cell type 1 activity and accelerates chemotherapy-induced bacterial clearance in a model of progressive pulmonary tuberculosis. JOURNAL OF INFECTIOUS DISEASES , 191 (2) 299 - 306.

Herzmann, C and Kinloch, S and Johnson, M (2005) Rash in an HIV-postive patient. Atazanavir. HIV Medicine , 6 379 - ?.

Hue, S and Clewley, JP and Cane, PA and Pillay, D (2005) Investigation of HIV-1 transmission events by phylogenetic methods: requirement for scientific rigour. AIDS , 19 (4) 449 - 450.

Hue, S and Pillay, D and Clewley, JP and Pybus, OG (2005) Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups. P NATL ACAD SCI USA , 102 (12) 4425 - 4429. 10.1073/pnas.0407534102.
An open access publication

Huggett, J and Dheda, K and Bustin, S and Zumla, A (2005) Real-time RT-PCR normalisation; strategies and considerations. GENES IMMUN , 6 (4) 279 - 284. 10.1038/sj.gene.6364190.

Hunt, JRF and Martinelli, R and Adams, VC and Rook, GAW and Brunet, LR (2005) Intragastric administration of Mycobacterium vaccae inhibits severe pulmonary allergic inflammation in a mouse model. CLIN EXP ALLERGY , 35 (5) 685 - 690. 10.1111/j.1365-2222.2005.02239.x.

J

Jalal, H and Bibby, DF and Tang, JW and Bennett, J and Kyriakou, C and Peggs, K and Cubitt, D and Brink, NS and Ward, KN and Tedder, RS (2005) First reported outbreak of diarrhea due to adenovirus infection in a hematology unit for adults. J CLIN MICROBIOL , 43 (6) 2575 - 2580. 10.1128/JCM.43.6.2575-2580.2005.

Jenkins, C and Claxton, AP and Shorten, RJ and McHugh, TD and Gillespie, SH (2005) Rifampicin resistance in tuberculosis outbreak, London, England. EMERG INFECT DIS , 11 (6) 931 - 934.
An open access publication. A version is also available from UCL Discovery.
file

Johnson, VA and Brun-Vezinet, F and Clotet, B and Conway, B and Kuritzkes, DR and Pillay, D and Schapiro, J and Telenti, A and Richman, D (2005) Update of the Drug Resistance Mutations in HIV-1: 2005. Topics in HIV Medicine , 13 (1) 51 - 57.

K

Kantor, R and Katzenstein, DA and Efron, B and Carvalho, AP and Wynhoven, B and Cane, P and Clarke, J and Sirivichayakul, S and Soares, MA and Snoeck, J and Pillay, C and Rudich, H and Rodrigues, R and Holguin, A and Ariyoshi, K and Bouzas, MB and Cahn, P and Sugiura, W and Soriano, V and Brigido, LF and Grossman, Z and Morris, L and Vandamme, AM and Tanuri, A and Phanuphak, P and Weber, JN and Pillay, D and Harrigan, PR and Camacho, R and Schapiro, JM and Shafer, RW (2005) Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration. PLoS Medicine , 2 (4) e112 - ?.
An open access publication

Kaushik, N and Fear, D and Richards, SCM and McDermott, CR and Nuwaysir, EF and Kellam, P and Harrison, TJ and Wilkinson, RJ and Tyrrell, DAJ and Holgate, ST and Kerr, JR (2005) Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. J CLIN PATHOL , 58 (8) 826 - 832. 10.1136/jcp.2005.025718.

Kellam, P and Swift, S and Tucker, A and Vinciotti, V and Martin, N and Orengo, C and Liu, X (2005) Consensus clustering and functional interpretation of gene expression data. Genome Biology , 5 (94)
An open access version is available from UCL Discovery
file

Kellam, PAG and C, (2005) Genome scale views of host and pathogen interactions. In: Encyclopaedia of Genetics, Genomics, Proteomics and Bioinformatics. Wiley

Kibbler, C (2005) Defining invasive fungal infections in neutropenic or stem cell transplant patients. J Antimicrob Chemother , 56 Suppl 1 i12 - i16. 10.1093/jac/dki219.

Kinloch-de Loes, S and Hoen, B and Smith, DE and Autran, B and Lampe, FC and Phillips, AN and Goh, LE and Andersson, J and Tsoukas, C and Sonnerborg, A and Tambussi, G and Girard, PM and Bloch, M and Battegay, M and Carter, N and El Habib, R and Theofan, G and Copper, DA and Perrin, L and QUEST Study Grp, (2005) Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection. J INFECT DIS , 192 (4) 607 - 617.

L

Lalvani, A and Richeldi, L and Kunst, H and Dheda, K and Chang, J-S and Kim, LU and Huggett, JF and Johnson, MA and Zumla, A and Rook, GAW and Pai, M and Riley, LW and Colford Jr, JM (2005) Interferon gamma assays for tuberculosis. Lancet Infectious Diseases , 5 (6) 322 - 327.

Lewis, F and Frost, SDW and Pillay, D and Mathews, WC and Richman, DD and Little, SJ and Brown, AJL (2005) Transmitted HIV drug resistance: effect of treatment intensification in limiting the epidemic. In: ANTIVIRAL THERAPY. (pp. S129 - S129). INT MEDICAL PRESS LTD

Lewis, F and Frost, SDW and Pillay, D and Mathews, WC and Richman, DD and Little, SJ and Brown, AJL (2005) Transmitted HIV drug resistance: effect of treatment intensification in limiting the epidemic. In: ANTIVIRAL THERAPY. (pp. S129 - S129). INT MEDICAL PRESS LTD

Lienhardt, C and Zumla, A (2005) BCG: the story continues. LANCET , 366 (9495) 1414 - 1416. 10.1016/S0140-6736(05)67535-6.

M

Masquelier, BND and Bhaskaran, K and Deenan, P and Gifford, R and Balestre, E and Jorgensen, LB and Pedersen, C and van der Hoek, L and Prins, M and Balotta, C and Longo, B and Kucherer, C and Poggensee, G and Ortiz, M and de Mendoza, C and Gill, J and Fleury, H and Porter, K and CASCASE Collaboration, (2005) Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms - Data from seroconverters in the CASCADE collaboration from 1987 to 2003. JAIDS-J ACQ IMM DEF , 40 (5) 505 - 511.

Mattes, FM and Hainsworth, EG and Hassan-Walker, AF and Burroughs, AK and Sweny, P and Griffiths, PD and Emery, VC (2005) Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir. J INFECT DIS , 191 (1) 89 - 92.

McHugh, TD and Batt, SL and Shorten, RJ and Gosling, RD and Uiso, L and Gillespie, SH (2005) Mycobacterium tuberculosis lineage: A naming of the parts. TUBERCULOSIS , 85 (3) 127 - 136.

McLean, AR and May, RM and Pattison, JM and Weiss, RA (2005) SARS: A case study in emerging infections. (1 vols). Oxford University Press: Oxford.

Milne, RS and Nicola, AV and Whitbeck, JC and Eisenberg, RJ and Cohen, GH (2005) Glycoprotein D receptor-dependent, low-pH-independent endocytic entry of herpes simplex virus type 1. Journal of Virology , 79 (11) 6655 - 6663. 10.1128/JVI.79.11.6655-6663-2005.

Milne, RSB and Nicola, AV and Whitbeck, JC and Eisenberg, RJ and Cohen, GH (2005) Glycoprotein D receptor-dependent, low-pH-Independent Endocytic entry of herpes simplex virus type 1. J VIROL , 79 (11) 6655 - 6663. 10.1128/JVI.79.11.6655-6663.2005.

Myers, RE and Gale, CV and Harrison, A and Takeuchi, Y and Kellam, P (2005) A statistical model for HIV-1 sequence classification using the subtype analyser (STAR). Bioinformatics , 21 (17) 3535 - 3540. 10.1093/bioinformatics/bti569.

N

Nebbia, G and Chawla, A and Schutten, M and Atkinson, C and Raza, M and Johnson, M and Geretti, AM (2005) Adenovirus viraemia and dissemination unresponsive to antiviral therapy in advanced HIV-1 infection. AIDS , 19 (12) 1339 - 1340.

Neil, S.J.D. and McKnight, A. and Gustafsson, K. and Weiss, R.A. (2005) HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation. Blood , 105 (12) pp. 4693-4699. 10.1182/blood-2004-11-4267.

Neil, SJD and Aasa-Chapman, MMI and Clapham, PR and Nibbs, RJ and McKnight, A and Weiss, RA (2005) The promiscuous CC chemokine receptor D6 is a functional coreceptor for primary isolates of human immunodeficiency virus type 1 (HIV-1) and HIV-2 on astrocytes. J VIROL , 79 (15) 9618 - 9624. 10.1128/JVI.79.15.9618-9624.2005.
An open access publication

Neil, SJD and McKnight, A and Gustafsson, K and Weiss, RA (2005) HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation. BLOOD , 105 (12) 4693 - 4699. 10.1182/blood-2004-11-4267.

O

O'Niel, P and Frasier, K and Wang, Z and Kellam, P and Kok, JNAL and X, (2005) Pyramidic Clustering of Large Scale Microarray Imagery. The Computer Journal , 48 (4) 466 - 479.

O'Sullivan, DM and McHugh, TD and Gillespie, SH (2005) Analysis of rpoB and pncA mutations in the published literature: an insight into the role of oxidative stress in Mycobacterium tuberculosis evolution? J ANTIMICROB CHEMOTH , 55 (5) 674 - 679. 10.1093/jac/dki069.
An open access version is available from UCL Discovery
file

Onyebujoh, P and Zumla, A and Ribeiro, I and Rustomjee, R and Mwaba, P and Gomes, M and Grange, JM (2005) Treatment of tuberculosis: present status and future prospects. B WORLD HEALTH ORGAN , 83 (11) 857 - 865.
An open access publication

P

Pachiadakis, L and Pollara, G and Chain, BM and Naoumov, NV (2005) Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence? LANCET INFECT DIS , 5 (5) 296 - 304.

Pao, D and Fisher, M and Hue, S and Dean, G and Murphy, G and Cane, PA and Sabin, CA and Pillay, D (2005) Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections. AIDS , 19 (1) 85 - 90.

Paterson, PJ and Seaton, S and Yeghen, T and McHugh, TD and McLaughlin, J and Hoffbrand, AV and Kibbler, CC (2005) Molecular confirmation of invasive infection caused by Chaetomium globosum. J CLIN PATHOL , 58 (3) 334 - 334.

Paterson, PJ and Seaton, S and Yeghen, T and McHugh, TD and McLaughlin, J and Hoffbrand, AV and Kibbler, CC (2005) Molecular confirmation of invasive infection caused byChaetomium globosum. Journal of Clinical Pathology , 58 (3) 334 - 334.
An open access version is available from UCL Discovery
file

Perrin, FMR and Breen, RAM and Lipman, MCI and Shorten, RJ and Gillespie, SH and McHugh, TD (2005) Is there a relationship between Mycobacterium tuberculosis strain type and TB paradoxical reaction? THORAX , 60 (8) 706 - 707. 10.1136/thx.2005.044321.
An open access version is available from UCL Discovery
file

Perrin, FMR and Parsons, YN and Breen, RAM and Islam, J and McHugh, TD and Lipman, MCI and Gillespie, SH (2005) Messenger RNA as a marker of treatment response in pulmonary tuberculosis. In: THORAX. (pp. II44 - II44). B M J PUBLISHING GROUP

Pillay, D and Green, H and Matthias, R and Dunn, D and Phillips, A and Sabin, C and Evans, B and Evans, B and Cane, P and Burns, S and Cameron, S and Chrystie, I and Churchill, D and Clarke, J and Easterbrook, P and Zuckerman, M and Goldberg, D and Gompels, M and Hale, T and Robb, G and Leigh-Brown, A and Geretti, AM and Pillay, D and Phillips, A and Sabin, C and Kellam, P and Dunn, D and Porter, K and Matthias, R and Orkin, C and Pozniak, A and Smit, R and Tilston, P and Williams, I and UK Collaborat Grp HIV Drug Res, (2005) Estimating HIV-1 drug resistance in antiretroviral-treated individuals in the United Kingdom. JOURNAL OF INFECTIOUS DISEASES , 192 (6) 967 - 973.

Pillay, D and Parry, J (2005) Multidrug resistant HIV and rapid progression of disease reported from New York. Euro Surveill , 10 (2) E050224.2 - ?.
An open access publication

Pollara, G and Katz, DR and Chain, BM (2005) LIGHTing up dendritic cell activation: Immune regulation and viral exploitation. J CELL PHYSIOL , 205 (2) 161 - 162. 10.1002/jcp.20473.

Pollara, G and Kwan, A and Newton, PJ and Handley, ME and Chain, BM and Katz, DR (2005) Dendritic cells in viral pathogenesis: protective or defective? INT J EXP PATHOL , 86 (4) 187 - 204.
An open access publication

Purdie, K and Surentheran, T and Sterling, J and Bell, L and McGregor, J and Proby, C and Harwood, C and Leigh, I and Breuer, J (2005) Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. In: JOURNAL OF INVESTIGATIVE DERMATOLOGY. (pp. A125 - A125). BLACKWELL PUBLISHING INC

Purdie, KJ and Surentheran, T and Sterling, JC and Bell, L and McGregor, JM and Proby, CM and Harwood, CA and Breuer, J (2005) Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. J INVEST DERMATOL , 125 (1) 98 - 107. 10.1111/j.0022-202X.2005.23635.x.

Q

Quinlivan, M and Breuer, J (2005) Molecular and therapeutic aspects of varicella-zoster virus infection. Expert Rev Mol Med , 7 (15) 1 - 24. 10.1017/S146239940500966X.

Quinlivan, M and Gershon, AA and Steinberg, SP and Breuer, J (2005) An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of Varicella-Zoster virus. J MED VIROL , 75 (1) 174 - 180. 10.1002/jmv.20253.

R

Relander, T and Johansson, M and Olsson, K and Ikeda, Y and Takeuchi, Y and Collins, M and Richter, J (2005) Gene transfer to repopulating human CD34(+) cells using amphotropic-, GALV-, or RD114-pseudotyped HIV-1-based vectors from stable producer cells. MOL THER , 11 (3) 452 - 459. 10.1016/j.ymthe.2004.10.014.

Relander, T and Johansson, M and Olsson, K and Ikeda, Y and Takeuchi, Y and Collins, MK and Richter, J (2005) Gene transfer to repopulating CD34+ cells using amphotropic, GALV or RD114 pseudotyped HIV-1 based vectors from stable producer cells. Molecular Therapy , 11 425 - 429.

Rigopoulou, EI and Suri, D and Chokshi, S and Mullerova, I and Rice, S and Tedder, RS and Williams, R and Naoumov, NV (2005) Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: Antiviral and immunological activity. HEPATOLOGY , 42 (5) 1028 - 1036. 10.1002/hep.20888.

Rook, GA and Martinelli, R and Brunet, LR (2005) Modelling gene-environment interactions in Th1- and Th2-dominated diseases of laboratory animals. Ernst Schering Res Found Workshop (50) 45 - 68.
An open access version is available from UCL Discovery
file

Rook, GAW (2005) Old Friends and homoeostasis. In: IMMUNOLOGY. (pp. 19 - 19). BLACKWELL PUBLISHING

Rook, GAW and Brunet, LR (2005) Microbes, immunoregulation, and the gut. GUT , 54 (3) 317 - 320. 10.1136/gut.2004.053785.
An open access version is available from UCL Discovery
file

Rook, GAW and Brunet, LR (2005) Old friends for breakfast. CLIN EXP ALLERGY , 35 (7) 841 - 842. 10.1111/j.1365-2222.2005.02112.x.
An open access version is available from UCL Discovery
file

Rook, GAW and Brunet, LR (2005) Chronic inflammatory disorders, the gut and the 'Old Friends' hypothesis. In: Colombel, JF and Gasche, C and Scholmerich, J and Vucelic, B, (eds.) Inflammatory Bowel Disease: Translation From Basic Research to Clinical Practice. (pp. 43 - 58). SPRINGER

Rook, GAW and Dheda, K and Zumla, A (2005) Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting? VACCINE , 23 (17-18) 2115 - 2120.
An open access version is available from UCL Discovery
file

Rook, GAW and Dheda, K and Zumla, A (2005) Immune responses to tuberculosis in developing countries: implications for new vaccines. NAT REV IMMUNOL , 5 (8) 661 - 667. 10.1038/nri1666.

Rook, GAW and Martinelli, R and Rosa Brunet, L (2005) The "Old Friends" hypothesis: how early contact with certain microorganisms may influence regulatory circuits. In: Hodgson, DM and Coe, CL, (eds.) Perinatal Programming: Early Life Determinants of Adult Health and Disease. (183 - 194). Taylor and Francis: London and New York.

S

Sadiq, ST and Taylor, S and Copas, AJ and Bennett, J and Drake, SM and Kirk, S and Pillay, D and Weller, IV (2005) The effects of urethritis on Seminal Plasma HIV-1 RNA loads in HIV positive patients not receiving antiretroviral therapy. Sexually Transmitted Diseases , 81 120 - 123.

Sadiq, ST and Taylor, S and Copas, AJ and Bennett, J and Kaye, S and Drake, SM and Kirk, S and Pillay, D and Weller, IVD (2005) The effects of urethritis on seminal plasma HIV-1 RNA loads in homosexual men not receiving antiretroviral therapy. SEX TRANSM INFECT , 81 (2) 120 - 123. 10.1136/sti.2004.010249.

Samonakis, DN and Cholongitas, E and Triantos, CK and Griffiths, P and Dhillon, AP and Thalheimer, U and Patch, DW and Burroughs, AK (2005) Sustained,spontaneous disapperance of serum HCV-RNA under immunosuppression after liver transplantation for HCV cirrhosis. Journal of Hepatology , 43 1091 - 1093.

Samonakis, DN and Triantos, CK and Thalheimer, U and Quaglia, A and Leandro, G and Teixeira, R and Papatheodoridis, GV and Sabin, CA and Rolando, N and Davies, S and Dhillon, AP and Griffiths, P and Emery, V and Patch, DW and Davidson, BR and Rolles, K and Burroughs, AK (2005) Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation. LIVER TRANSPLANT , 11 (4) 386 - 395. 10.1002/lt.20344.

Shahid, M and Leedham-Green, M and Breuer, J (2005) Does adherence to universal precautions correlate with the prevalence of blood-borne infections? J HOSP INFECT , 60 (3) 289 - 290. 10.1016/j.jhin.2004.12.006.

Shahid, M and Leedham-Green, M and Breuer, J (2005) Does the adherence of universal precautions correlate with the prevalence of blood borne infections? In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 52 - 53). BLACKWELL PUBLISHING

Shorten, RJ and Gillespie, SH and Sule, O and Lipman, M and McHugh, TD (2005) Molecular strain typing of <i>M. tuberculosis</i> isolates from a suspected outbreak involving a faulty bronchoscope. Journal of Hospital Infection , 61 (1) 86 - 87. 10.1016/jhin.2004.12.013.

Shorten, RJ and Gillespie, SH and Sule, O and Lipman, M and McHugh, TD (2005) Molecular strain typing of M. tuberculosis isolates from a suspected outbreak involving a faulty bronchoscope. J HOSP INFECT , 61 (1) 86 - 87. 10.1016/j.jhin.2004.12.013.

Steele, AJ and Al-Chalabi, A and Ferrante, K and Cudkowicz, ME and Brown, RH and Garson, JA (2005) Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives. NEUROLOGY , 64 (3) 454 - 458.

Steffen, R and Nothdurft, H and Rombo, L and Castelli, F and Zuckerman, JN (2005) Vaccination against Enterotoxigenic E coli - a cause of travellers’ diarrhoea. Journal of Travel Medicine , 12 102 - 107.

Stephens, R and Rashid, M and Dixon, G and Baxendale, H and Mythen, M (2005) Do levels of antibody to endotoxin core change with time? Shock , 23 189 - ?.

Strang, BL and Takeuchi, Y and Relander, T and Richter, J and Bailey, R and Sanders, DA and Collins, MK and Ikeda, Y (2005) HIV-1 vectors with alphavirus envelope glycoproteins produced from stable packaging cells. Journal of Virology , 79 1765 - 1671.

Strang, BL and Takeuchi, Y and Relander, T and Richter, J and Bailey, R and Sanders, DA and Collins, MKL and Ikeda, Y (2005) Human immunodeficiency virus type 1 vectors with alphavirus envelope glycoproteins produced from stable packaging cells. J VIROL , 79 (3) 1765 - 1771. 10.1128/JVI.79.3.1765-1771.2005.

T

Takeuchi, Y (2005) PERV genetics: is recombination a threat? In: XENOTRANSPLANTATION. (pp. 370 - 370). BLACKWELL PUBLISHING

Takeuchi, Y and Magre, S and Patience, C (2005) The potential hazards of xenotransplantation: an overview. REV SCI TECH OIE , 24 (1) 323 - 334.

Talukder, Y and Gopal, R and Andrews, N and Glenn, M and Breuer, J and Brown, D (2005) Development and evaluation of Varicella zoster virus ELISA for oral fluid suitable for epidemiological studies. J VIROL METHODS , 128 (1-2) 162 - 167. 10.1016/j.jviromet.2005.04.013.

Tang, JW and Eames, I and Li, Y and Taha, YA and Wilson, P and Bellingan, G and Ward, KN and Breuer, J (2005) Door-opening motion can potentially lead to a transient breakdown in negative-pressure isolation conditions: the importance of vorticity and buoyancy airflows. J HOSP INFECT , 61 (4) 283 - 286. 10.1016/j.jhin.2005.05.017.

Tang, JW and Eames, I and Li, Y and Taha, YA and Wilson, P and Bellingan, G and Ward, KN and Breuer, J (2005) Door-opening motion can potentially lead to a transient breakdown in negative-pressure isolation conditions: the importance of vorticity and buoyancy airflows. Journal of Hospital Infection , 61 (4) 283 - 286.

Taylor, GM and Young, DB and Mays, SA (2005) Genotypic Analysis of the Earliest Known Prehistoric Case of Tuberculosis from Britain. Journal of Clinical Microbiology , 43 (5) 2236 - 2240. 10.1128/JCM.43.5.2236-2240.2005.

Temperton, N.J. and Chan, P.K. and Simmons, G. and Zambon, M.C. and Tedder, R.S. and Takeuchi, Y. and Weiss, R.A. (2005) Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes. Emerging Infectious Diseases , 11 (3) pp. 411-416.
An open access publication

Temperton, NJ and Chan, PK and Simmons, G and Zambon, MC and Tedder, RS and Takeuchi, Y and Weiss, RA (2005) Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes. EMERG INFECT DIS , 11 (3) 411 - 416.
An open access publication

Thapa, N and Lydyard, P and Rook, GAW and Stanford, JL (2005) The proportions of CD4, CD8, CD3 T cells in peripheral circulation of patients with pulmonary tuberculosis. SAARC Journal of Tuberculosis, Lung Diseases & HIV/AIDS , 2 (1) 23 - 28.

Thapa, N and Rook, GAW and Donoghue, H and Stanford, JL (2005) Detection of intracellular TNF-α and IL-10 in CD4 and CD8 cells of patients with pulmonary tuberculosis using a flow cytometer. SAARC Journal of Tuberculosis, Lung Diseases & HIV/AIDS , 2 (1) 10 - 14.

Tiwana, H and Clow, KJ and Hall, C and Feavers, IM and Charalambous, BM (2005) The immunogenicity of a conformationally restricted peptide mimetic of meningococcal lipooligosaccharide. SCAND J IMMUNOL , 62 (4) 385 - 392. 10.1111/j.1365-3083.2005.01671.x.

Tiwana, H. and Clow, K.J. and Hall, C. and Feavers, I.M. and Charalambous, B.M. (2005) The immunogenicity of a conformationally restricted peptide mimetic of meningococcal lipooligosaccharide. Scandinavian Journal of Immunology , 62 (4) pp. 385-392. 10.1111/j.1365-3083.2005.01671.x.

Towers, GJ (2005) Control of viral infectivity by tripartite motif proteins. HUM GENE THER , 16 (10) 1125 - 1132.

V

Vinciotti, V and Khanin, R and D'Alimonte, D and Liu, X and Cattini, N and Hotchkiss, G and Bucca, G and de Jesus, O and Rasaiyaah, J and Smith, CP and Kellam, P and Wit, E (2005) An experimental evaluation of a loop versus a reference design for two-channel microarrays. Bioinformatics , 21 (4) 492 - 501.

W

Warrens, AN and Persey, M and Powis, SH and Fertleman, M and Zumla, A (2005) A Guide to the MRCP Part 2 Written Paper. Hodder Arnold

Weiss, RA (2005) Robert Koch: The grandfather of cloning? CELL , 123 (4) 539 - 542. 10.1016/j.cell.2005.11.001.

Weissenborn, SJ and Nindl, I and Purdie, K and Harwood, C and Proby, C and Breuer, J and Majewski, S and Pfister, H (2005) Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J INVEST DERMATOL , 125 (1) 93 - 97. 10.1111/j.0022-202X.2005.23733.x.

Wenzel, R and Del Favero, A and Kibbler, C and Rogers, T and Rotstein, C and Mauskopf, J and Morris, S and Schlamm, H and Troke, P and Marciniak, A (2005) Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients. J Antimicrob Chemother , 55 (3) 352 - 361. 10.1093/jac/dkh535.

Whitehouse, T and Cepeda, JA and Shulman, R and Aarons, L and Nalda-Molina, R and Tobin, C and MacGowan, A and Shaw, S and Kibbler, C and Singer, M and Wilson, APR (2005) Pharmacokinetic studies of linezolid and teicoplanin in the critically ill. J ANTIMICROB CHEMOTH , 55 (3) 333 - 340. 10.1093/jac/dki014.

Wilson, APR and Bellingan, G and Singer, M (2005) Isolation of patients with MRSA infection - Reply. LANCET , 365 (9467) 1304 - 1305.

Wright, M and Forton, D and Main, J and Goldin, R and Torok, E and Tedder, R and Grant, P and Thursz, M and Naoumov, N and Millson, C and Mills, PR and Bassendine, M and Thomas, HC and Investigators, UKMHCVT (2005) Treatment of histologically mild hepatitis C virus infection with interferon and ribavirin: a multicentre randomized controlled trial. JOURNAL OF VIRAL HEPATITIS , 12 (1) 58 - 66. 10.1111/j.1365-2893.2005.00575.x.

X

Xu, L and Pozniak, A and Wildfire, A and Stanfield-Oakley, SA and Mosier, SA and Ratcliffe, D and Workman, J and Joall, A and Myers, R and Smit, E and Cane, PA and Greenberg, AL and Pillay, D (2005) Emergence and evolution of enfuvirtide resistance following long-term therapy involves heptad repeat 2 mutations within gp41. ANTIMICROB AGENTS CH , 49 (3) 1113 - 1119.

Y

Ylinen, LMJ and Keckesova, Z and Wilson, SJ and Ranasinghe, S and Towers, GJ (2005) Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5 alpha alleles. J VIROL , 79 (18) 11580 - 11587. 10.1128/JVI.79.18.11580-11587.2005.

Yousaf, N and Gould, DJ and Aganna, E and Hammond, L and Mirakian, RM and Turner, MD and Hitman, GA and McDermott, MF and Chernajovsky, Y (2005) Tumor necrosis factor receptor I from patients with tumor necrosis factor receptor-associated periodic syndrome interacts with wild-type tumor necrosis factor receptor I and induces ligand-independent NF-kappaB activation. Arthritis Rheum , 52 (9) 2906 - 2916. 10.1002/art.21268.

Youshya, S and Purdie, K and Breuer, J and Proby, C and Sheaf, MT and Oliver, RTD and Baithun, S (2005) Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis. J CLIN PATHOL , 58 (2) 207 - 210. 10.1136/jcp.2004.017152.

Z

Zuckerman, JN (2005) Maritime health & travel medicine and malaria. Journal of Travel Medicine & Infectious Disease , 3 59 - 60.

Zuckerman, JN (2005) Travel by air: health considerations. Weekly Epidemiological Record , 21 (80) 181 - 191.

Zuckerman, JN (2005) Vaccine advice for travellers. Practitioner , 249 (1669) 286 - 290.

Zuckerman, JN (2005) Protection against hepatitis B. In: Thomas, HC and Lemon, S and Zuckerman, AJ, (eds.) Viral Hepatitis. (370 - 377). Blackwell Publishing Ltd

Zuckerman, JN (2005) International Travel & Health 2005. In: World, HO, (ed.) International Travel & Health 2005. (1 - 210). World Health Organisation

Zuckerman, JN and Connor, BA and von Sonnenburg, F (2005) Hepatitis A and B booster recommendations: Implications for travelers. CLIN INFECT DIS , 41 (7) 1020 - 1026.

Zuckerman, JN and Langer, B (2005) Hepatitis B vaccination in a school age population - a feasibility study. Journal of Medical Virology 47 - 54.

Zuckerman, JN and Zuckerman, AJ (2005) Current issues in hepatitis B vaccines. In: Bittar, E, (ed.) Principles of Medical Biology The Liver in Biology and Disease. Elsevier Science

Zumla, A (2005) Towards improving outcomes of fatal pulmonary infections. CURR OPIN PULM MED , 11 (3) 187 - 188.

This list was generated on Tue May 21 10:16:39 2013 BST.